Florida laboratory settles federal allegations involving referral-related compensation practices.
A Florida-based laboratory has agreed to pay nearly $9.8 million to resolve allegations involving improper business arrangements with health care providers and consultants, according to the U.S. Department of Justice (DOJ). NeoGenomics Laboratories Inc. reached the settlement after federal officials alleged that the company violated the False Claims Act through compensation practices connected to referral candidates for lab testing services. The agreement resolves the government’s claims without a determination of liability.
Federal authorities alleged that NeoGenomics provided consulting services to certain health care providers at rates below fair market value. According to the government, those arrangements were connected to providers who referred patients to NeoGenomics for lab testing. Officials contended that offering services at discounted rates could influence referral decisions and potentially violate federal health care laws.
The allegations centered on NeoGenomics’ Laboratory Clinical Initiative program. Through that program, the company worked with health care providers interested in developing in-house laboratory capabilities, including flow cytometry and Fluorescence In-Situ Hybridization (FISH). Federal investigators claimed that some of the consulting services offered through the program were priced below fair market value and were intended to encourage...
Listen to the story WASHINGTON – Following President Trump’s speech on Thursday where he peddled lies about the 2020 election and attempted to sow doubt in the 2026 and 2028 elections, U.S. Senate ...